From: Overcoming the limitations of locally administered oncolytic virotherapy
No. | Nanomaterial | Characteristics of nanomaterial | Oncolytic adenovirus | Therapeutic transgene | Complexation Method | Reference |
---|---|---|---|---|---|---|
1 | deoxycholic acid-conjugated PEI (DA3) | Cationic nanomaterial | RdB-KOX | Artificial transcriptional repressor zinc-finger protein specific to vascular endothelial growth factor (VEGF) promoter | Electrostatic interaction | [27] |
2 | mPEG-PEI-g-Arg-S-S-Arg-g-PEI-mPEG (PPSA) | Cationic/bioreducible nanomaterial | DWP418 | Human relaxin | Electrostatic interaction | [24] |
3 | multidegradable bioreducible core-cross-linked PEI (rPEI) | Cationic/bioreducible nanomaterial | RdB/shMet | Short hairpin RNA specific to c-Met | Electrostatic interaction | [29] |
4 | PEGylated paclitaxel conjugated to arginine grafted bioreducible polymer (APP) | Cationic, bioreducible, and chemodrug-conjugated nanomaterial | oAd-vp53 | p53 variant that is resistant to p53 inactivation | Electrostatic interaction | [32] |
5 | lithium 3-[2-(perfluoroalkyl)ethylthio]propionate) & 25 kDa branched PEI (PEI-Mag2) | Cationic/magnetic nanomaterial | dl520 | No therapeutic transgene | Electrostatic interaction | [33] |
6 | polybrene-modified nanoparticles (PB-Mag1) & silica-modified nanoparticle decorated with branched PEI (SO-Mag2) | Cationic/magnetic nanomaterial | dl520 | No therapeutic transgene | Electrostatic interaction | [34] |
7 | PEGylated and cross-linked iron oxide nanoparticles (PCION) | Cationic/magnetic nanomaterial | HmT | No therapeutic transgene | Electrostatic interaction | [35] |
8 | Injectable alginate gel | Biodegradable gel | DWP418 | Human relaxin | Gel encapsulation | [36] |
9 | silk-elastin like protein polymer hydrogel (SELP hydrogel) | Biodegradable gel | Ad-C-Met | Short hairpin RNA specific to c-Met | Gel encapsulation | [37] |
10 | in situ cross-linkable gelatin hydrogels using gelatin-hydroxyphenyl propionic acid (GHPA gel) | Biodegradable gel | oAd-TRAIL | Secretable trimeric tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) | Gel encapsulation | [38] |
11 | in situ cross-linkable gelatin hydrogels using gelatin-hydroxyphenyl propionic acid (GHPA gel) | Biodegradable gel | RdB/IL-12/GMCSF | Interleukin (IL)-12 and granulocyte-macrophage colony-stimulating factor (GM-CSF) | Gel encapsulation | [44] |
12 | gold nanorod (GNR) | Laser-induced hyperthermia | RdB-K35/KOX | Artificial transcriptional repressor zinc-finger protein specific to VEGF promoter | No complexation | [50] |